Galectin Therapeutics Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer. The company's lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in a Phase 2 clinical study in MASH patients with advanced fibrosis and a second Phase 2b clinical trial in MASH patients with compensated cirrhosis and portal hypertension. It has a joint venture co-owned by SBH Sciences, Inc. to research and develop small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| TwoSigma | quant | 467.1K | $1.30M | 0.00% | Added+2711.6% | 2026-03-31 |
| StateStreet | passive | 258.4K | $721.02K | 0.00% | Added+6.7% | 2026-03-31 |
| RenTech | quant | 147.9K | $412.64K | 0.00% | New | 2026-03-31 |
| FidelityFMR | fundamental | 13.0K | $36.23K | 0.00% | Added+1.4% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-05-15 | -0.06 | -0.08 | -33.33% |
| 2026-03-31 | -0.10 | -0.08 | +20.00% |
| 2025-11-14 | -0.11 | -0.13 | -18.18% |
| 2025-08-14 | -0.16 | -0.12 | +25.00% |
| 2025-05-15 | -0.11 | -0.15 | -36.36% |
| 2025-03-31 | -0.16 | -0.19 | -18.75% |
| 2024-11-14 | -0.20 | -0.18 | +10.00% |
| 2024-08-13 | -0.16 | -0.20 | -25.00% |
| 2024-05-15 | -0.16 | -0.19 | -18.75% |
| 2024-03-29 | -0.16 | -0.16 | — |
| 2023-11-13 | -0.16 | -0.24 | -50.00% |
| 2023-08-14 | -0.21 | -0.15 | +28.57% |
| 2023-05-15 | -0.21 | -0.19 | +9.52% |
| 2023-03-30 | -0.17 | -0.18 | -5.88% |
| 2022-11-14 | -0.20 | -0.14 | +30.00% |
| 2022-08-15 | -0.19 | -0.16 | +15.79% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| GALT | +11.01% | -15.44% | -39.42% | +92.37% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +8.04% | -10.80% | -35.98% | +79.68% |